Alan E. Walts, Ph.D.
Alan E. Walts is a U.S.-based Venture Partner with Advent Life Sciences, a business advisor to Henri Termeer and an advisor to various life science companies. He has over 25 years of industry experience in corporate venture capital, business development, research and development, and general management from his time at Genzyme Corporation. Alan most recently managed Genzyme’s corporate venture fund, Genzyme Ventures (now Sanofi-Genzyme BioVentures), where he identified and closed several new investments, and managed a portfolio of direct and LP investments. Alan earlier led business and corporate development activities in Genzyme’s therapeutics business. His roles at Genzyme also included President of Genzyme Pharmaceuticals and VP of Chemistry and Biopolymer Research. Alan received a Ph.D. in Chemistry from MIT, carried out postdoctoral research in Biochemistry at MIT, and completed the Executive Program for Management Development at Harvard Business School.
In addition to serving as Chairman of Aura, Alan is also Chairman of X4 Pharmaceuticals.